ENDEFR
Home › Netherlands › C.P. Pharmaceuticals International C.V.

C.P. Pharmaceuticals International C.V.

commanditaire vennootschap (CV) · Capelle aan den IJssel, Netherlands · LEI 549300DIVQE4U6N6TG78
LEI active

Summary

C.P. Pharmaceuticals International C.V. is registered in the Netherlands and entered in the “Business Register (KvK)” under number 24280998. Its legal form is commanditaire vennootschap (CV). According to GLEIF, its ultimate parent is PFIZER INC. (United States), which is also its direct parent. That group has 147 subsidiaries with LEIs in 26 countries, 39 of them in the Netherlands. It has 9 direct subsidiaries in GLEIF data; 5 of them have a lapsed LEI. The LEI was first issued on 19 Feb 2014 and the record was last updated on 27 Mar 2026; the next renewal is due by 12 Apr 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formcommanditaire vennootschap (CV)
RegisterBusiness Register (KvK) · Register website
Registration number24280998
Registration authorityThe Netherlands Chamber of Commerce
JurisdictionNetherlands
Registered addressRivium Westlaan 142, 2909 LD Capelle aan den IJssel, Netherlands
Headquarters address235 EAST 42ND STREET, 10017 NEW YORK, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)19 Dec 1997
LEI549300DIVQE4U6N6TG78
LEI statusactive
LEI first issued19 Feb 2014
LEI record last updated27 Mar 2026
Next LEI renewal12 Apr 2027
Corroboration of the LEI recordfully corroborated

Group membership

View the whole group: 147 subsidiaries in 26 countries

Relationship to the parent

Direct parentUltimate parent
ParentPFIZER INC.PFIZER INC.
Accounting period1 Jan 2024 to 31 Dec 20241 Jan 2024 to 31 Dec 2024
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Relationship start19 Dec 199719 Dec 1997
Recorded at GLEIF since30 May 202430 May 2024
Last updated27 Mar 202627 Mar 2026
Record statuscurrentcurrent

Direct subsidiaries (9)

Other subsidiaries of the same direct parent (39)

and 27 more